11-71473632-A-C
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_018161.5(NADSYN1):c.612A>C(p.Gln204His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 1 in 1,613,280 control chromosomes in the GnomAD database, including 806,625 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_018161.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NADSYN1 | NM_018161.5 | c.612A>C | p.Gln204His | missense_variant | 8/21 | ENST00000319023.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NADSYN1 | ENST00000319023.7 | c.612A>C | p.Gln204His | missense_variant | 8/21 | 1 | NM_018161.5 | P1 | |
NADSYN1 | ENST00000528509.5 | c.612A>C | p.Gln204His | missense_variant, NMD_transcript_variant | 8/10 | 1 | |||
NADSYN1 | ENST00000525200.5 | c.513A>C | p.Gln171His | missense_variant, NMD_transcript_variant | 7/21 | 2 | |||
NADSYN1 | ENST00000530534.1 | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes ? AF: 1.00 AC: 152215AN: 152218Hom.: 76106 Cov.: 35
GnomAD3 exomes AF: 1.00 AC: 250495AN: 250498Hom.: 125246 AF XY: 1.00 AC XY: 135736AN XY: 135738
GnomAD4 exome AF: 1.00 AC: 1460932AN: 1460944Hom.: 730460 Cov.: 57 AF XY: 1.00 AC XY: 726760AN XY: 726768
GnomAD4 genome ? AF: 1.00 AC: 152333AN: 152336Hom.: 76165 Cov.: 35 AF XY: 1.00 AC XY: 74493AN XY: 74494
ClinVar
Submissions by phenotype
Vertebral, cardiac, renal, and limb defects syndrome 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at